SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter The IPO market is currently red-hot. Three companies in the last week traded more than 85% above their issue price — two of which traded more than 100% higher! Without a doubt, there’s a feeling of euphoria that exists currently. But this euphoria should be a cautionary sign to[…]
06.13.19 Secondary Announcement
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
03.18.19 Secondary Announcement
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
1.10.19 Secondary Announcement
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
10.29.18 Secondary Announcement
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
Pricings 8.21.18
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
UXIN Limited #IPO Preview ($UXIN)
Company: Uxin Limited Symbol: UXIN Description: They are the largest used car e-commerce platform in China in terms of both the number of transactions facilitated and total GMV in 2017, according to iResearch. Trade Date: 6/27 Shares: 38 million ADS Price Range: $10.50-$12.50 Underwriter(s): Morgan Stanley, Goldman Sachs (Asia) LLC, J.P. Morgan, CICC, China Renaissance[…]
Translate Bio, Inc. #IPO Preview ($TBIO)
Company: Translate Bio, Inc. Symbol: TBIO Description: They are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction Trade Date: 6/28 Shares: 7.7 million Price Range: $12.00-$14.00 Underwriter(s): Citigroup, Leerink Partners, Evercore ISI Terms Added; 6-18-18 Link to Prospectus[…]
Neuronetics, Inc. #IPO Preview ($STIM)
Company: Neuronetics, Inc. Symbol: STIM Description: They are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorder Trade Date: 6/28 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): Piper Jaffray, William Blair Co-Manager(s): Canaccord Genuity, BTIG, JMP Securities Terms[…]
Neon Therapeutics Inc #IPO Preview ($NTGN)
Company: Neon Therapeutics Symbol: NTGN Description: They are a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens Trade Date: 6/27 Shares: 6.25 million Price Range: $15.00-$17.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Mizuho Securities Co-Manager(s): Oppenheimer &[…]
IPO Pipeline Update (6.15.18)
IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: Navios[…]
Kezar Life Sciences, Inc. #IPO Preview ($KZR)
Company: Kezar Life Sciences, Inc. Symbol: KZR Description: They are a clinical-stage biotechnology company, discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. Trade Date: 6/21 Shares: 4.67 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Cowen, Wells Fargo, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow[…]
Autolus Therapeutics #IPO Preview ($AUTL)
Company: Autolus Therapeutics Limited Symbol: AUTL Description: They are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Trade Date: 6/22 Shares: 7.81 million Price Range: $15.00-$17.00 Underwriter(s): Goldman Sachs & Co., Jefferies Co-Manager(s): Wells Fargo Securities, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow Business: They[…]
IPO Pipeline Update – Ending 6.08.18
IPO Boutique keeps apprised of the active pipeline. Currently there are 76 active IPOs in the pipeline as of June 8, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: Forty[…]
Verrica Pharmaceuticals #IPO Preview
Company: Verrica Pharmaceuticals Inc. Symbol: VRCA Description: They are a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. Trade Date: 6/15 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): BofA Merrill Lynch, Jefferies, Cowen Terms Added: 6-5-18 Link to Prospectus Link[…]
Secondaries Announced 5.23.18
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
Pluralsight, Inc. #IPO Preview ($PS)
Company: Pluralsight, Inc. Symbol: PS Description: Pluralsight is an enterprise software company committed to closing the global technology skills gap. Trade Date: 5/17 Shares: 20.7 million Price Range: $10.00-$12.00 Underwriter(s): Morgan Stanley, J.P. Morgan, Barclays, BofA Merrill Lynch Co-Manager(s): First Analysis Securities, Needham & Co., Raymond James, SunTrust Robinson Humphrey Terms Added: 5-7-18 UPDATE: New[…]
Smartsheet Inc #IPO Preview ($SMAR)
Company: Smartsheet Inc. Symbol: SMAR Description: They are a leading cloud-based platform for work execution, enabling teams and organizations to plan, capture, manage, automate, and report on work at scale, resulting in more efficient processes and better business outcomes. Shares: 11.6 million Price Range: $10.00-$12.00 Trade Date: 4/27 Underwriter(s): Morgan Stanley, J.P. Morgan, Jefferies, RBC[…]
Alzheon Inc. #IPO Preview ($ALZH)
Company: Alzheon Inc. Symbol: ALZH Description: They are a clinical stage biopharmaceutical company with a Phase 3-ready program in Alzheimers disease and a discovery platform of small molecules for the inhibition of protein misfolding in neurodegenerative disorders. Trade Date: 4/12 Shares: 5 million Price Range: $13.00-$15.00 Underwriter(s): Citigroup, Piper Jaffray Co-Manager(s): Canaccord Genuity, JMP Securities[…]
IPO Weekly Recap: Dropbox dazzles in public markets’ debut
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]